Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9K Buy
584
+31
+6% +$334 0.01% 1644
2026
Q1
$5K Buy
553
+41
+8% +$449 ﹤0.01% 1778
2025
Q4
$6K Hold
512
﹤0.01% 1803
2025
Q3
$8K Sell
512
-1
-0.2% -$15 ﹤0.01% 1704
2025
Q2
$7K Buy
513
+299
+140% +$5.33K ﹤0.01% 1698
2025
Q1
$5K Buy
214
+2
+0.9% +$71 ﹤0.01% 1723
2024
Q4
$8K Buy
212
+1
+0.5% +$47 0.01% 1626
2024
Q3
$11K Hold
211
0.01% 1475
2024
Q2
$7K Buy
211
+1
+0.5% +$40 ﹤0.01% 1704
2024
Q1
$12K Sell
210
-137
-39% -$6.78K 0.01% 1424
2023
Q4
$15K Sell
347
-1
-0.3% -$31 0.01% 1296
2023
Q3
$9K Sell
348
-284
-45% -$5.9K 0.01% 1466
2023
Q2
$15K Sell
632
-4
-0.6% -$69 0.01% 1251
2023
Q1
$9K Buy
636
+6
+1% +$95 0.01% 1343
2022
Q4
$9K Buy
+630
New +$8.9K 0.01% 1360

Other funds holding BHVN

Covestor's BHVN Position: Q2 2026 in Review

Covestor increased its Biohaven (BHVN) stake by 5.6% in Q2 2026, buying an estimated $334 and bringing the position to 584 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1644.

Covestor first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $15K in Q4 2023. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Covestor held 584 shares of Biohaven worth $9K as of Q2 2026.
  • Covestor bought 31 Biohaven shares in Q2 2026, an estimated $334.
  • Biohaven made up 0.01% of Covestor's portfolio in Q2 2026, its #1644 holding.
  • Covestor first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Covestor's Biohaven position peaked at $15K in Q4 2023.
  • 188 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.